<DOC>
	<DOCNO>NCT00774332</DOCNO>
	<brief_summary>A Phase II Study CODOX-M/ IVAC Relapsed/Refractory ALL</brief_summary>
	<brief_title>A Phase II Study CODOX-M/ IVAC Relapsed/Refractory ALL</brief_title>
	<detailed_description>The feasibility evaluate term complete remission rate , duration complete remission , disease-free survival , overall survival , toxicity .</detailed_description>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>Patients relapsed/resistant acute lymphoblastic leukemia Patients must 15 65 year age . Estimated life expectancy 3 month ECOG performance status 2 low , Karnofsky scale &gt; 60 ( see appendix I ) Adequate cardiac function ( EF &gt; 45 % ) echocardiogram MUGA scan Adequate kidney function ( estimate Ccr &gt; 50 ml/min ) Patients CNS involvement leukemic blast exclude . Patients extramedullary relapse ( ) exclude .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>